Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen plus physiotherapy for knee osteoarthritis feasibility trial
ACTRN12623001344684Phase 4Active, not recruiting
- Sponsor
- Dr Cathy Chapple
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of naproxen and omeprazole in knee osteoarthritis (OA), sponsored by Dr Cathy Chapple. Primary endpoint: Feasibility. Started Apr 2024; status: active, not recruiting.
02
Drugs
naproxenomeprazole
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12623001344684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623001344684.